Autoimmune diseases associated with drugs, chemicals and environmental factors.
about
Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burdenMultiorgan autoimmune inflammation, enhanced lymphoproliferation, and impaired homeostasis of reactive oxygen species in mice lacking the antioxidant-activated transcription factor Nrf2Occupational silica exposure and risk of various diseases: an analysis using death certificates from 27 states of the United StatesAcceleration of autoimmunity by organochlorine pesticides in (NZB x NZW)F1 mice.Silica exposure and systemic vasculitisRheumatic diseases induced by drugs and environmental factors: the state-of-the-art - part oneRheumatic diseases induced by drugs and environmental factors: the state-of-the-art - part twoSmall molecules as friends and foes of the immune system.Is occupational exposure to solvents associated with an increased risk for developing systemic scleroderma?Hair dyes as a risk for autoimmunity: from systemic lupus erythematosus to primary biliary cirrhosis.A prospective study of lupus and rheumatoid arthritis in relation to deployment in support of iraq and afghanistan: the millennium cohort study.Environmental pathways to autoimmune diseases: the cases of primary biliary cirrhosis and multiple sclerosis.The X and why of xenobiotics in primary biliary cirrhosisA genetic approach to the prediction of drug side effects: bleomycin induces concordant phenotypes in mice of the collaborative cross.Methods of evaluating immunotoxicity.Autoantibodies from mice exposed to Libby amphibole asbestos bind SSA/Ro52-enriched apoptotic blebs of murine macrophagesBleomycin and the skin.Aluminum is a potential environmental factor for Crohn's disease induction: extended hypothesis.Differential diagnosis of scleroderma and pseudoscleroderma.Genetic polymorphisms of CYP2D6 oxidation in patients with autoimmune bullous diseases."Omics" Technologies and the Immune System (a) , (b).Dysregulation of the immune system caused by silica and asbestos.Worldwide incidence and prevalence of pediatric onset systemic lupus erythematosus.Asbestos induces reduction of tumor immunity.Environment and lupus-related diseases.Functions of the aryl hydrocarbon receptor in the skin.Environmental risk factors of systemic sclerosis.Endocrine-disrupting chemicals and skin manifestations.Occupational and environmental scleroderma. Systematic review and meta-analysis.Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.Presumed isotretinoin-induced, concomitant autoimmune thyroid disease and ocular myasthenia gravis: a case reportAryl hydrocarbon receptor protects against bacterial infection by promoting macrophage survival and reactive oxygen species production.ANCA-positive vasculitis induced by thioridazine: confirmed by rechallenge.Alterations in T-lymphocyte sub-set profiles and cytokine secretion by PBMC of systemic lupus erythematosus patients upon in vitro exposure to organochlorine pesticides.Superantigen influence in conjunction with cytokine polymorphism potentiates autoimmunity in systemic lupus erythematosus patients.Abnormal epigenetic modifications in peripheral blood mononuclear cells from patients with alopecia areata.
P2860
Q22255575-60397751-1939-4B09-A894-6F84611823C7Q24170511-C8D888CD-1B8F-4F04-8C95-4A89DFDEC51DQ24718525-9C450E81-4A41-43F1-B7E5-2D649AD53104Q24811621-BDAF2A2C-EA20-42E2-87F5-B4393B91E855Q24817062-AC8BBBB7-3A17-45E4-A429-3767BC3BAA30Q26738462-17ADCFC8-D229-4129-ADAD-531A70591950Q28080204-A151673B-67DE-4E25-BF04-73751A63B886Q33852354-3359ABE9-8471-4DA4-A484-D1A1ED28CEFEQ34872370-2418724E-0227-4545-B79A-42D87CB8B4A7Q35309953-74AC50B4-A027-4CFD-9A85-DD4F6041136EQ35579663-EDE2EF1D-CC97-40DF-887B-47B356C55125Q35674181-8B5495C3-1BC6-40E8-A5ED-D04C635C1C60Q35916081-E3EF55A2-73AE-453E-9E2E-9C495BB7B296Q36441496-8D74D411-5A7E-4192-A21B-41F7B781F34DQ36546265-D3E59F87-75B0-40A7-B1E3-CD4A83950D33Q36593698-D3F4408E-CCA2-442C-89DE-F3B0A7E6D8D6Q36620749-735C36EF-FFD1-49B7-9FAB-6F7545A3A310Q36931389-AF610003-4DE2-4494-A230-E3C21AB6349BQ36988400-DD0B6511-A92A-4D90-8737-E84CEDC2E35FQ37327228-99988B80-7A01-4FBF-B3C0-35146F6942B2Q37658722-9453A821-B3F6-4AEB-B2E6-40C5B067800DQ37789761-461C4D25-32DB-4107-A36B-15461DCBE003Q37902377-EBCD4E79-DDD5-44FC-9CF5-00A78C8966C5Q37946900-D587918B-7C2F-43A2-9FF4-30E3E540D0CBQ37953846-95ADC0F1-CF3D-41CB-8A8A-786450DF45D1Q38129298-F8094854-88BB-4ED7-97C4-F388A827C6A3Q38542589-CD2F45D9-658A-473E-B1F7-5AC4C485D696Q38882275-49B91D2A-5B1D-4397-AF5B-500A9D8D5AAAQ39018767-0FF2C230-57D2-4F58-A7F5-B52F411F071DQ39437352-9E934E59-EEAA-4B2C-B78D-C5F2EE201E40Q42431529-F1702F1D-6FF7-42AC-B552-375B55ED1707Q44161216-85760E2A-957A-4188-8DD3-0A6EFF957AFBQ44230056-A4575B9C-1481-4436-AB32-4A68112EB2CFQ52732451-81E668D3-A09B-419F-B0E4-7D178CC3A096Q53804977-26B50904-CA59-4CB6-85D8-1DDF331470B7Q54347680-48032692-D17F-4189-B3CC-F78412310508
P2860
Autoimmune diseases associated with drugs, chemicals and environmental factors.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Autoimmune diseases associated with drugs, chemicals and environmental factors.
@ast
Autoimmune diseases associated with drugs, chemicals and environmental factors.
@en
type
label
Autoimmune diseases associated with drugs, chemicals and environmental factors.
@ast
Autoimmune diseases associated with drugs, chemicals and environmental factors.
@en
prefLabel
Autoimmune diseases associated with drugs, chemicals and environmental factors.
@ast
Autoimmune diseases associated with drugs, chemicals and environmental factors.
@en
P1433
P1476
Autoimmune diseases associated with drugs, chemicals and environmental factors.
@en
P2093
P304
P356
10.1016/S0378-4274(99)00220-9
P478
P577
2000-03-01T00:00:00Z